Navigation Links
Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
Date:2/13/2008

cines and Diagnostics.

Product sales were, in millions:

Three Months Ended Dec. 31, Year Ended Dec. 31,

2007 2006 Increase 2007 2006 Increase

Clinical diagnostics $49.7 $45.4 10 % $199.2 $171.2 16 %

Blood screening $42.7 $40.1 6 % $171.7 $154.1 11 %

Total product sales $92.4 $85.5 8 % $370.9 $325.3 14 %

Collaborative research revenues in the fourth quarter of 2007 were $5.4 million, compared to $1.2 million in the prior year period. This increase resulted from several factors, including:

-- Research reimbursement and milestone payments from 3M related to the

companies' collaboration to develop rapid tests for

healthcare-associated infections.

-- Research reimbursement and milestone payments from 3M related to the

companies' collaboration for food testing, which was terminated in the

fourth quarter.

-- Funds received from the US Department of Defense for prostate cancer

research.

For the full year 2007, collaborative research revenues were $16.6 million, compared to $15.9 million in the prior year, an increase of 4% that resulted primarily from the factors described above. These increases were partially offset by the reclassification of revenue associated with investigational use of the PROCLEIX WNV assay. Beginning in the third quarter of 2006, the Company began recording all revenue associated with this assay in product sales, rather than in collaborative research revenues. The assay was approved by the US Food and Drug Administration (FDA) for use on Gen-Probe's enhanced semi-automated instrument system (eSAS) in December of 2005, and for use on the TIGRIS system in March of 2007.

Royalty and license revenues for the fourth quarter of 2007 were $1.1 million, compared to $4.4 million in the prior year
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Carl Hull Named President and Chief Operating Officer of Gen-Probe
2. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
5. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
6. Imagenetix Inc. Reports Third Fiscal Quarter Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Post Your Comments:
*Name:
*Comment:
*Email: